CD8+T cells are not required for vaccine-induced immunity against Leishmania amazonensis in IL-12/23P40-/- C57BL/6 mice

Microbes and Infection

Volumn 9, Issue 9, 2007, Pages 1124-1134

  Hernández Sanabria, Mayra Xiomara ^a   Afonso, Luís Carlos Crocco ^b   Golgher, Denise ^a   Tafuri, Wagner Luiz ^a   Vieira, Leda Quercia ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Adjuvant; CD8+; Leishmania; Leishmaniasis; Parasite; Protozoa; Vaccine

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 23; LEISHMANIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; INFECTION PREVENTION; INTERFERON PRODUCTION; LEISHMANIA; LEISHMANIASIS; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12 SUBUNIT P40; LEISHMANIA; LEISHMANIASIS; LEISHMANIASIS VACCINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL;

ANIMALIA; LEISHMANIA AMAZONENSIS; MUS; PROTOZOA;

EID: 34548038607     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.05.016     Document Type: Article

References (35)

1. Neva F., and Sacks D. Leishmaniasis. In: Warren K.S., and Mahmound A.A.S. (Eds) (1990), McGraw-Hill Information Services Co, New York, NY 296-309
2. Almeida R.P., Barral-Netto M., De Jesus A.M., De Freitas L.A., Carvalho E.M., and Barral A. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice. Am. J. Trop. Med. Hyg. 54 (1996) 178-184
3. Sacks D., and Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2 (2002) 845-858
4. Afonso L.C., and Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61 (1993) 2952-2959
5. Jones D.E., Buxbaum L.U., and Scott P. IL-4-independent inhibition of il-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165 (2000) 364-372
6. Soong L., Xu J.C., Grewal I.S., Kima P., Sun J., Longley B.J., Ruddle N.H., McMahon-Pratt D., and Flavell R.A. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4 (1996) 263-273
7. Oliveira M.A., Santiago H.C., Lisboa C.R., Ceravollo I.P., Trinchieri G., Gazzinelli R.T., and Vieira L.Q. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis. Exp. Parasitol. 95 (2000) 96-105
8. Barral-Netto M., Von Sohsten R.L., Teixeira M., dos Santos W.L., Pompeu M.L., Moreira R.A., Oliveira J.T., Cavada B.S., Falcoff E., and Barral A. In vivo protective effect of the lectin from Canavalia brasiliensis on BALB/c mice infected by Leishmania amazonensis. Acta Trop. 60 (1996) 237-250
9. Soong L., Chang C.H., Sun J., Longley Jr. B.J., Ruddle N.H., Flavell R.A., and McMahon-Pratt D. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158 (1997) 5374-5383
10. Terabe M., Kuramochi T., Ito M., Hatabu T., Sanjoba C., Chang K.P., Onodera T., and Matsumoto Y. CD4+ cells are indispensable for ulcer development in murine cutaneous Leishmaniasis. Infect. Immun. 68 (2000) 4574-4577
11. Hernandez S.M.X., Barcante T.A., Vilela L., Tafuri W.L., Afonso L.C., and Vieira L.Q. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40. Immunol. Lett. 105 (2006) 38-47
12. Mayrink W., Santos G.C., Toledo V.P., Guimaraes T.M., Hado-Coelho G.L., Genaro O., and Da Costa C.A. Vaccination of C57BL/10 mice against cutaneous Leishmaniasis using killed promastigotes of different strains and species of Leishmania. Rev. Soc. Bras. Med. Trop. 35 (2002) 125-132
13. Sypek J.P., Chung C.L., Mayor S.E., Subramanyam J.M., Goldman S.J., Sieburth D.S., Wolf S.F., and Schaub R.G. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177 (1993) 1797-1802
14. Afonso L.C., Scharton T.M., Vieira L.Q., Wysocka M., Trinchieri G., and Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263 (1994) 235-237
15. + T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J. Immunol. 168 (2002) 3992-4000
16. + T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection. Infect. Immun. 71 (2003) 3172-3182
17. Costa C.A., Afonso L.C.C., Toledo V.P.C.P., Tavares C.A.P., Genaro O., and Mayrink W. Evaluation of an industrialized non-living promastigote vaccine against cutaneous leishmaniasis. Parassitologia 34 (1992) 45-51
18. Courret N., Prina E., Mougneau E., Saraiva E.M., Sacks D.L., Glaichenhaus N., and Antoine J.C. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29 (1999) 762-773
19. Saldanha J.C., Gargiulo D.L., Silva S.S., Carmo-Pinto F.H., Andrade M.C., Varez-Leite J.I., Teixeira M.M., and Cara D.C. A model of chronic IgE-mediated food allergy in ovalbumin-sensitized mice. Braz. J Med. Biol. Res. 37 (2004) 809-816
20. McMahon-Pratt D., and Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?. Immunol. Rev. 201 (2004) 206-224
21. + T cells provide an early source of IFN-gamma. J. Immunol. 170 (2003) 2399-2408
22. + T cell generation with enhanced granzyme B expression by IL-27. J. Immunol. 175 (2005) 1686-1693
23. Coelho E.A.F., Tavares C.A.P., Carvalho F.A.A., Chaves K.F., Teixeira K.N., Rodrigues R.C., Charest H., Matlashewski G., Gazzinelli R.T., and Fernandes A.P. Immune responses induced by the Leishmania (Leishmania) donovani A2 Antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect. Immun. 71 (2003) 3988-3994
24. Overath P., and Harbecke D. Course of Leishmania infection in beta 2-microglobulin-deficient mice. Immunol. Lett. 37 (1993) 13-17
25. Zijlstra M., Li E., Sajjadi F., Subramani S., and Jaenisch R. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342 (1989) 435-438
26. Scharton-Kersten T., Afonso L.C., Wysocka M., Trinchieri G., and Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154 (1995) 5320-5330
27. Huber M., Timms E., Mak T.W., Rollinghoff M., and Lohoff M. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect. Immun. 66 (1998) 3968-3970
28. Wang Z.E., Reiner S.L., Hatam F., Heinzel F.P., Bouvier J., Turck C.W., and Locksley R.M. Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J. Immunol. 151 (1993) 2077-2086
29. + T cells are a biologically relevant source of macrophage inflammatory protein-1 alpha in vivo. J. Immunol. 162 (1999) 5423-5428
30. Kim J.J., Nottingham L.K., Sin J.I., Tsai A., Morrison L., Oh J., Dang K., Hu Y., Kazahaya K., Bennett M., Dentchev T., Wilson D.M., Chalian A.A., Boyer J.D., Agadjanyan M.G., and Weiner D.B. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J. Clin. Invest. 102 (1998) 1112-1124
31. He D., Wu L., Kim H.K., Li H., Elmets C.A., and Xu H. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J. Immunol. 177 (2006) 6852-6858
32. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278 (2003) 1910-1914
33. Happel K.I., Zheng M., Young E., Quinton L.J., Lockhart E., Ramsay A.J., Shellito J.E., Schurr J.R., Bagby G.J., Nelson S., and Kolls J.K. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170 (2003) 4432-4436
34. Khader S.A., Pearl J.E., Sakamoto K., Gilmartin L., Bell G.K., Jelley-Gibbs D.M., Ghilardi N., deSauvage F., and Cooper A.M. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175 (2005) 788-795
35. Wozniak T.M., Ryan A.A., and Britton W.J. Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J. Immunol. 177 (2006) 8684-8692